Coronavirus Notebook: Moderna To Build UK Vaccines Plant, US Approves First MAb For COVID-19
Executive Summary
Sanofi/GSK’s VidPrevtyn Beta has become the seventh COVID-19 vaccine to be approved by the UK regulator, the MHRA.
You may also be interested in...
Reform Of MHRA & Clinical Trials Needed To Unlock UK’s ‘Medical & Scientific Potential’
Moderna says that if the right investments are made in reforming the Medicines and Healthcare products Regulatory Agency, the National Health Service and other public health bodies, the UK will be in a strong position to mitigate “future shocks” in the health care system.
Sanofi & GSK Win COVID-19 Vaccine Approval In EU Using Immunobridging Trials
The European Medicines Agency said it was possible to use immunobridging studies to authorize COVID-19 vaccines now that a number of COVID-19 vaccines authorized in the EU are proven to be safe and effective and can be used as comparators in trials.
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.